Detection of carbapenem resistance mechanisms in difficult-to-treat Pseudomonas aeruginosa clinical isolates from a tertiary care hospital in Egypt
Dalia Salem, Manar Zaiton, Ahmed El-Shenawy, Heba Dahroug, Samah El-Dein, Doaa Gamal, Azza Ali Althoqapy, Amr AW Mohamed, Mohamed A Shemis, Manal Diab, Soheir S Maklad · 2026
Read Detection of carbapenem resistance mechanisms in difficult-to-treat Pseudomonas aeruginosa clinical isolates from a tertiary care hospital in Egypt by Dalia Salem, Manar Zaiton, Ahmed El-Shenawy, Heba Dahroug, Samah El-Dein, Doaa Gamal, Azza Ali Althoqapy, Amr AW Mohamed, Mohamed A Shemis, Manal Diab, Soheir S Maklad (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13543481.txt.
Description
A stubborn lung germ in Egyptian hospitals shrugs off last-line drugs, and Dalia Salem and co-authors mapped how, in work from twenty twenty-six. Fifty-two drug-proof isolates from one large hospital were classed by how wide their resistance ran. Gene tests hunted five enzyme genes, plus pump and pore dials.
Near half the isolates met the hardest class, hardest to treat. Enzyme genes showed in near all of that class, led by one gene in three-quarters. Several isolates stacked two or three such genes. Pump overdrive and pore loss added their share. The map warns that gene checks, not drug trials, should steer care for these infections.
Catalog record
| CREATOR | Dalia Salem, Manar Zaiton, Ahmed El-Shenawy, Heba Dahroug, Samah El-Dein, Doaa Gamal, Azza Ali Althoqapy, Amr AW Mohamed, Mohamed A Shemis, Manal Diab, Soheir S Maklad |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |